Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq GlobeNewswire LA JOLLA, Calif., June 21, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NasdaqCM: ARTL, ARTLW) (the “Company” or “Artelo Biosciences”), …
Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq GlobeNewswire LA JOLLA, Calif., June 21, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NasdaqCM: ARTL, ARTLW) (the “Company” or “Artelo Biosciences”), …
Air T Funding: An Unusual Trust Preferred Stock IPO Has Begun Trading On The Nasdaq Seeking Alpha Overview of Air T Funding’s new trust preferred stock – AIRTP. Brief look at the company. Comparison with all other trust preferred securities.
Form 8-K Rimini Street, Inc. For: Jun 20 StreetInsider.com UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d).
Form 8-K Rimini Street, Inc. For: Jun 20 – StreetInsider.com Read More »
Form 8-K Accelerize Inc. For: Jun 18 StreetInsider.com WASHINGTON, DC 20549. FORM 8-K. CURRENT REPORT PURSUANT. TO SECTION 13 OR 15(d) OF THE. SECURITIES EXCHANGE ACT OF 1934.
Form 8-K Accelerize Inc. For: Jun 18 – StreetInsider.com Read More »
Form 8-K Moxian, Inc. For: Jun 21 StreetInsider.com CURRENT REPORT. Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934. Date of Report (Date of earliest event reported): June 21, 2019 …
Form 8-K Moxian, Inc. For: Jun 21 – StreetInsider.com Read More »
Wintrust Financial Corporation (WTFC) Analysts See $1.66 EPS The MAK Daily Investors sentiment increased to 1.11 in Q1 2019. Its up 0.08, from 1.03 in 2018Q4. It is positive, as 40 investors sold Wintrust Financial Corporation shares.
Wintrust Financial Corporation (WTFC) Analysts See $1.66 EPS – The MAK Daily Read More »
Form POS AM INVIVO THERAPEUTICS HOLD StreetInsider.com Table of Contents. As filed with the Securities and Exchange Commission on June 21, 2019. Registration No. 333-224424. Registration No. 333-225768.
Form POS AM INVIVO THERAPEUTICS HOLD – StreetInsider.com Read More »
Source: Streetwise Reports 06/21/2019 Canaccord Genuity explained in a report its reasons for severely reducing its target price on this cobalt company post offer. In a June 18 research note, analyst Eric Zaunscherb reported that Canaccord Genuity reduced its target price on Cobalt 27 Capital Corp. (KBLT:TSX.V; CBLLF:OTC; 27O:FSE) by about 68% to CA$5 per
Analyst: Bid to Buy Battery Metals Firm Good Deal for Acquirer Read More »
Source: Streetwise Reports 06/21/2019 The rationale for investing in this Canadian firm is presented in a ROTH Capital Partners report. In a June 19 research note, analyst Joe Reagor reported that ROTH Capital Partners initiated coverage on Integra Resources Corp. (ITR:TSX.V; IRRZF:OTCQB) with a Buy rating and a CA$1.40 per share price target. The company’s
Coverage Initiated on Company with 'Strong Gold Project,' Experienced Team Read More »